People of all demographics are impacted by mental illness, which has become a widespread and international health problem. Effective treatment and support for mental illnesses depend on early discovery and precise diagnosis. Notably, delayed diagnosis may lead to suicidal thoughts, destructive behaviour, and death. Manual diagnosis is time-consuming and laborious. With the advent of AI, this research aims to develop a novel mental health disorder detection network with the objective of maximum accuracy and early discovery. For this reason, this study presents a novel framework for the early detection of mental illness disorders using a multi-modal approach combining speech and behavioral data. This framework preprocesses and analyzes two distinct datasets to handle missing values, normalize data, and eliminate outliers. The proposed NeuroVibeNet combines Improved Random Forest (IRF) and Light Gradient-Boosting Machine (LightGBM) for behavioral data and Hybrid Support Vector Machine (SVM) and K-Nearest Neighbors (KNN) for voice data. Finally, a weighted voting mechanism is applied to consolidate predictions. The proposed model achieves robust performance and a competitive accuracy of 99.06% in distinguishing normal and pathological conditions. This framework validates the feasibility of multi-modal data integration for reliable and early mental illness detection.
mental disorder detectionearly diagnosisspeech analysisbehavioral data
Diabetes, a chronic condition affecting millions worldwide, necessitates early intervention to prevent severe complications. While accurately predicting diabetes onset or progression remains challenging due to complex and imbalanced datasets, recent advancements in machine learning offer potential solutions. Traditional prediction models, often limited by default parameters, have been superseded by more sophisticated approaches. Leveraging Bayesian optimization to fine-tune XGBoost, researchers can harness the power of complex data analysis to improve predictive accuracy. By identifying key factors influencing diabetes risk, personalized prevention strategies can be developed, ultimately enhancing patient outcomes. Successful implementation requires meticulous data management, stringent ethical considerations, and seamless integration into healthcare systems. This study focused on optimizing the hyperparameters of an XGBoost ensemble machine learning model using Bayesian optimization. Compared to grid search XGBoost (accuracy: 97.24%, F1-score: 95.72%, MCC: 81.02%), the XGBoost with Bayesian optimization achieved slightly improved performance (accuracy: 97.26%, F1-score: 95.72%, MCC:81.18%). Although the improvements observed in this study are modest, the optimized XGBoost model with Bayesian optimization represents a promising step towards revolutionizing diabetes prevention and treatment. This approach holds significant potential to improve outcomes for individuals at risk of developing diabetes.
The healthcare industry, aided by technology, leverages the Internet of Things (IoT) paradigm to offer patient/user-related services that are ubiquitous and personalized. The authorized repository stores ubiquitous data for which access-level securities are granted. These security measures ensure that only authorized entities can access patient/user health information, preventing unauthorized entries and data downloads. However, recent sophisticated security and privacy attacks such as data breaches, data integrity issues, and data collusion have raised concerns in the healthcare industry. As healthcare data grows, conventional solutions often fail due to scalability concerns, causing inefficiencies and delays. This is especially true for multi-key authentication. Dependence on conventional access control systems leads to security flaws and authorization errors caused by static user behaviour models. This article introduces an Opportunistic Access Control Scheme (OACS) for leveraging access-level security. This approach is a defendable access control scheme in which the user permissions are based on their requirement and data. After accessing the healthcare record, a centralized IoT security augmentation and assessment is provided. The blockchain records determine and revoke the access grant based on previous access and delegation sequences. This scheme analyses the possible delegation methods for providing precise users with interrupt-free healthcare record access. The blockchain recommendations are analyzed using a trained learning paradigm to provide further access and denials. The proposed method reduces false rates by 11.74%, increases access rates by 13.1%, speeds up access and processing by 12.36% and 13.23%, respectively, and reduces failure rates by 9.94%. The OACS decreases false rates by 10.64%, processing time by 15.62%, and failure rates by 10.95%.
Internet of Thingshealthcare data securityblockchainmachine learning
In the present scenario, cancerous tumours are common in humans due to major changes in nearby environments. Skin cancer is a considerable disease detected among people. This cancer is the uncontrolled evolution of atypical skin cells. It occurs when DNA injury to skin cells, or a genetic defect, leads to an increase quickly and establishes malignant tumors. However, in rare instances, many types of skin cancer occur from DNA changes tempted by infrared light affecting skin cells. This disease is a worldwide health problem, so an accurate and appropriate diagnosis is needed for efficient treatment. Current developments in medical technology, like smart recognition and analysis utilizing machine learning (ML) and deep learning (DL) techniques, have transformed the analysis and treatment of these conditions. These approaches will be highly effective for the recognition of skin cancer utilizing biomedical imaging. This study develops a Multi-scale Feature Fusion of Deep Convolutional Neural Networks on Cancerous Tumor Detection and Classification (MFFDCNN-CTDC) model. The main aim of the MFFDCNN-CTDC model is to detect and classify cancerous tumours using biomedical imaging. To eliminate unwanted noise, the MFFDCNN-CTDC method initially utilizes a sobel filter (SF) for the image preprocessing stage. For the segmentation process, Unet3+ is employed, providing precise localization of tumour regions. Next, the MFFDCNN-CTDC model incorporates multi-scale feature fusion by combining ResNet50 and EfficientNet architectures, capitalizing on their complementary strengths in feature extraction from varying depths and scales of the input images. The convolutional autoencoder (CAE) model is utilized for the classification method. Finally, the parameter tuning process is performed through a hybrid fireworks whale optimization algorithm (FWWOA) to enhance the classification performance of the CAE model. A wide range of experiments is performed to authorize the performance of the MFFDCNN-CTDC approach. The experimental validation of the MFFDCNN-CTDC approach exhibited a superior accuracy value of 98.78% and 99.02% over existing techniques under ISIC 2017 and HAM10000 datasets.
skin cancer detectionskin lesion classificationmulti-scale feature fusionconvolutional neural networks
The recent approval of the nasal spray combination of mometasone (MOM) and olopatadine (OLO) presents a significant analytical challenge, as only a single reported method exists for its determination, deviating from eco-friendly practices. This study addresses this critical gap by pioneering the application of machine learning techniques to develop robust UV spectrophotometric approach for the simultaneous quantification of MOM and OLO, along with two genotoxic impurities: 4-dimethylamino pyridine (DAP) and methyl para-toluene sulfonate (MTS). By simultaneously determining these highly concerning genotoxic impurities and active pharmaceutical ingredients, this method underscores its paramount significance in upholding rigorous pharmaceutical quality standards and safeguarding patient safety. Applying the multilevel-multifactor experimental design, the calibration set was meticulously chosen at five different concentrations, yielding 25 calibration mixtures with central levels of 4, 46.5, 2.5, and 3 µg/mL for MOM, OLA, MTS, and DAP, respectively. The key innovation lies in the strategic implementation of the Kennard-Stone Clustering Algorithm to create a robust validation set of thirteen mixtures, resolving the limitations of reported chemometric methods' random data splitting. This approach ensures unbiased evaluation across the full concentration space, improving the method's reliability and sustainability. The robustness of this approach was rigorously tested using five distinct chemometric models: principal component regression, classical least squares, partial least squares, genetic algorithm-partial least squares, and multivariate curve resolution-alternating least squares, demonstrating its broad applicability across diverse modeling techniques. All models successfully determined all components with excellent recovery, low bias-corrected prediction, and adequate limits of detection. The Greenness Index Spider Charts and the Green Solvents Selection Tool were used to choose environmentally conscious solvents. A comprehensive sustainability assessment employed six state-of-the-art tools, including the national environmental method index, complementary green analytical procedure index, analytical greenness metric, blue applicability grade index, carbon footprint analysis, and the red-green-blue 12 metrics. Favorable results across all metrics affirmed the method's eco-friendliness, real-world applicability, and cost-effectiveness, supporting sustainable development goals in pharmaceutical quality control processes.
International Journal of Computational Intelligence Systems · مجلد 18 (1)
Artificial intelligence (AI) transforms multiple businesses, including medical research, where AI-driven developments bring significant advantages. The application of machine learning algorithms enables medical researchers to examine large amounts of data accurately, which leads to the development of precise and effective treatment approaches. Lung cancer leads the list of critical healthcare issues because it remains the world’s most lethal form of cancer thus demanding innovative diagnostic tools for faster and accurate identification. The proposed study introduces an innovative method called CTGAN-RF which uses conditional tabular generative adversarial networks (CTGAN) and random forest (RF) classifier to detect lung cancer through synthetic data generation. The proposed model demonstrated superior performance by achieving a 0.9893 score of accuracy and 0.99 value for precision, F1 score, and recall. Extensive experimental evaluation for this method included testing nine classification algorithms. The implementation of different classifiers employed data balancing methods including SMOTE and borderline-SMOTE along with SMOTE ENN and unbalanced data configurations. Comparative analysis showed that CTGAN-RF consistently performed significantly better than traditional classifiers in dealing with class imbalance and improving prediction accuracy. After testing with fivefold cross-validation, the reliability of the model was further validated. In comparison to cutting-edge approaches for lung cancer diagnosis, the proposed methodology outperformed in terms of classification metrics. This in-depth evaluation of synthetic data augmentation with machine learning in lung cancer detection has helped in the development of personalized treatment strategies in the fight against such a life-threatening disease.
lung cancer detectionsynthetic data augmentationCTGANrandom forest
The hyoid bone has been identified as sexually dimorphic in various populations. The current study is a forerunner analysis that used three-dimensional multidetector computed tomography (3D MDCT) images of the hyoid bone to examine sexual dimorphism in the Egyptian population. A total of 300 subjects underwent neck CT imaging, with an additional 60 subjects randomly selected for model validation. Ten hyoid variables were measured. Initially, the dataset was subjected to discriminant analysis to predict sex and the critical variables associated with sexual dimorphism. Subsequently, machine learning approaches were employed to enhance the accuracy of sex determination. The results indicated that all measured dimensions of the hyoid bone were substantially larger in males confront to females. Discriminant functions combining four measurements (major and minor axes of the hyoid body, the distance between the lesser horns, and hyoid bone length) achieved a higher accuracy of sex prediction compared to univariate functions. The accuracies of machine learning models ranged from 0.8667 to 0.933 with precision, recall, and F1-scores also showing improvements. These findings underscore the robustness and reliability of hyoid bone in sex discrimination among Egyptians, supported by both traditional statistical methods and machine learning approaches, and could prove invaluable in forensic cases.
Journal of Advanced Trends in Medical Research · مجلد 2 (3) · 596-601
Background: Non-alcoholic fatty liver disease (NAFLD) is one of the causes of chronic liver diseases. Inconsistency in the microbiome population of individual guts and host–microbial interactions leads to low response in dietary and pharmacological-based treatments. This study aimed to develop and evaluate a metagenomic-guided, culturally adapted dietary and probiotic intervention to reduce hepatic fat and improve metabolic outcomes in obese Saudi adults with NAFLD. Materials and Methods: We combined gut metagenomic analysis, machine learning-based diet modelling and tailored probiotic supplementation to create an intervention platform. Probiotic specificity depends on functional deficits in bacteria participating in specific metabolic pathways, particularly bile acid metabolism. This technique supplements medication with microbiome-based drug processing. Results: At week 24, magnetic resonance imaging–proton density fat fraction (MRI-PDFF) decreased by −3.4 ± 2.2% (control), −8.9 ± 3.1% (diet) and −12.3 ± 3.8% (diet + probiotics); liver fat reduction was significant (analysis of variance (ANOVA) P = 0.0004). In the combined intervention, Faecalibacterium prausnitzii increased 2.3-fold (P = 0.003), faecal butyrate rose from 28.7 ± 4.1 to 45.2 ± 5.6 μmol/g (P = 0.002), faecal deoxycholic acid (fDCA) fell 34% (P = 0.010) with a rise in ursodeoxycholic acid (UDCA) (P = 0.015) and high-sensitivity C-reactive protein declined 42% (6.4 ± 1.7 to 3.7 ± 1.3 mg/L) versus 18% in controls (between-group P = 0.0008). Conclusion: Our precision-guided approach is a novel, scalable solution to managing NAFLD, leveraging the alignment of interactions between hosts, the microbiome and diet within a cultural context. The framework has the potential to optimise therapeutic response in high-risk Saudi communities, and the individual modulation of microbiomes on metabolic diseases is highlighted.
Smart healthcare is advancing through the integration of Cyber-Physical Systems (CPS), Internet of Things (IoT), and Artificial Intelligence (AI). This work presents an IoT-enabled Healthcare CPS (H-CPS) for early detection and classification of Obsessive-Compulsive Disorder (OCD). The proposed system employs a hybrid machine learning framework that combines Radial Basis Function (RBF) Neural Networks, Competitive Neural Networks, and Neuro-Symbolic AI within a CPS architecture to enable intelligent coordination across healthcare infrastructure. The H-CPS leverages IoT devices, LoRa-based communication, and cloud computing to implement an OCD detection system. Oxidative Stress Biomarkers (OSBs) serve as predictive indicators, distinguishing patients with OCD (POCD), genetically predisposed first-degree relatives (GFDR), and healthy controls (HC). The model comprises a competitive input layer, an RBF-based nonlinear transformation layer, and a competitive clustering layer, with Neuro-Symbolic AI applied for cluster labeling. Experimental evaluation on two independent datasets achieved high prediction accuracies (0.9492 and 0.9317), outperforming state-of-the-art clustering methods. A four-layer IoT prototype further demonstrated real-time feasibility with 1–2 second latency, confirming scalability for healthcare deployment.
obsessive-compulsive disorderearly detectionneuro-symbolic AIradial basis function neural network
Down syndrome (DS) is a genetic condition characterized by distinct facial features and developmental challenges, making early and accurate detection crucial for timely intervention and support. Traditional diagnostic methods often require specialized expertise, which can be resource intensive and inaccessible in many settings. In this study, we propose a novel artificial intelligence (AI)-driven approach to detecting DS using facial images, leveraging advancements in deep learning and machine learning for accurate and scalable diagnostics. A dataset of 168 facial images was curated from publicly accessible platforms, comprising 95 images of individuals without DS and 73 with the condition. The model was implemented using TensorFlow/PyTorch and employs RegNet X and Shifted Window Transformer (SWIN Transformer) for feature extraction, capturing both local and global facial features. To enhance feature representation, an attention-based fusion mechanism was applied, prioritizing the most discriminative patterns while filtering redundant information. For classification, an Extremely Randomized Tree (ExtraTrees) model was employed, known for its ability to efficiently handle high-dimensional data with strong generalization capabilities. The model was fine-tuned using Bayesian Optimization and Hyperband (BOHB), which optimized hyperparameters by balancing exploration and exploitation, thereby improving predictive performance. The final classification achieved a 99.2% accuracy with an area under the curve (AUC) of 1.00, demonstrating exceptional reliability in distinguishing DS from normal cases. By combining advanced feature extraction, fusion, and classification techniques, this study highlights the potential of AI to revolutionize DS diagnostics, offering a non-invasive, efficient, and scalable solution for early detection.
Down syndromeface classificationearly diagnosismodel interpretability
Journal of Advanced Trends in Medical Research · مجلد 2 (3) · 523-528
Background: Diabetic neuropathy is a common and disabling complication of type 2 diabetes (T2D), often linked to Vitamin B12 deficiency. Despite observed B12 malabsorption in T2D patients, the role of gut microbiota in this process is poorly understood. Methods: We established a novel fecal microbiota transplantation (FMT) model using samples from T2D patients stratified by B12 status and neuropathy severity, transplanted into germ-free mice. We assessed ileal expression of B12 transporters, serum B12 levels and cobalamin-related metabolites. Neuropathy progression was evaluated through nerve conduction studies and histopathological analysis. Microbial composition was analysed through 16S rRNA sequencing, and metabolomic data were obtained using ion mobility-enhanced liquid chromatography-mass spectrometry. Machine learning algorithms integrated microbial and host data to identify predictive patterns and therapeutic targets. Results: FMT from T2D donors with B12 deficiency led to decreased expression of B12 absorption markers and reduced serum B12 levels in recipient mice. These mice showed early signs of neuropathy, confirmed by slowed nerve conduction and structural nerve damage. Specific microbial taxa were significantly associated with altered B12 metabolism and indicators of neuropathy. Multiomics and machine learning analyses revealed key microbial signatures and metabolic pathways involved in B12 dysregulation. Conclusion: Gut microbiota plays a mechanistic role in Vitamin B12 malabsorption and the progression of diabetic neuropathy. This model provides a platform for microbiota-informed diagnostics and targeted interventions in T2D complications.
Hematological biomarkers have emerged as powerful tools in diagnosing Acute Heart Failure (AHF). This study introduces a novel diagnostic framework that integrates Explainable Artificial Intelligence (XAI) with Morris Sensitivity Analysis (MSA) to enhance both the interpretability and performance of machine learning models in AHF detection. A dataset consisting of 425 AHF patients and 430 controls was analyzed using eight machine learning models, including XGBoost, Histogram-based Gradient Boosting (histGB), Explainable Boosting Machine (EBM), and Random Forest. Model performance was evaluated through metrics such as AUC, accuracy, precision, recall, and Brier score. Hyperparameters were optimized via Bayesian optimization. Feature importance was assessed using MSA to identify variables with the highest predictive influence. The histGB model achieved the highest performance with an AUC of 87.93%. Both MSA and EBM consistently identified PDW, RDW-CV, NEU, NEU/LY ratio, age, and WBC as top predictive features across multiple models. These hematological markers demonstrated strong potential for early diagnosis and risk stratification in AHF patients. This study presents a clinically relevant, interpretable, and cost-effective diagnostic strategy that combines XAI with MSA for AHF prediction. The framework enhances clinical trust and provides a pathway toward personalized treatment by identifying accessible hematological biomarkers. The integration of explainability into AI models improves their transparency and applicability in real-world clinical settings.
Journal of Advanced Trends in Medical Research · مجلد 2 (3) · 620-628
Background: Precision oncology in advanced urologic malignancies frequently uses genomic markers, which are insufficient to fully represent tumour metabolic heterogeneity. This study investigated if integrative lipidomics – metabolomics profiling by surface-assisted laser desorption/ionisation mass spectrometry (SALDI-MS) and a supervised machine-learning pipeline could be leveraged to enable informed decision-making for targeted therapy selection. Methods: SALDI-MS was completed on resected or biopsy tumour material with concomitant Liquid Chromatography-mass spectrometry (MS)/MS-based annotations of lipids/metabolites. Features were harmonised and modelled with a hybrid graph neural network – Transformer classifier, using nested cross-validation as well as Delong tests for area under the curve comparison. A blinded retrospective cohort with matched clinical treatment decisions was used for evaluations. Results: Compared with matrix-assisted laser desorption/ionisation MS, nanostructured Si@Au SALDI-MS substrates enhanced the number of detected lipid/metabolite features by 47% from tissue sections. The integrative model found 37 high-parameter lipid – metabolite features, and enhanced discrimination compared with single dimensional models by 11%–18% ( P < 0.001). In a blinded cohort of 87 patients, the therapy-selection model performed with 79% accuracy compared with 48% for programmed death-ligand 1 immunohistochemistry alone; the mean area under the receiver operating characteristic in the ablation analyses was 0.91 ± 0.03. Conclusions: Integrative SALDI-MS lipidomics – metabolomics, together with machine learning, demonstrated promise to inform targeted therapy decisions in advanced urologic cancers, and deserves prospective validation.
Human Behavior and Emerging Technologies · مجلد 2025 (1)
ASD (autism spectrum disorder) is a neurodevelopmental disorder affecting people’s social interaction, learning, and communication skills worldwide. It is a behaviorally distinct syndrome that is combined with several unknown and known disorders. The symptoms include sleep disorders, seizures, gastrointestinal tract symptoms, anxiety, wandering, hyperactivity/attention‐deficit disorder, and obesity. Hence, early detection of ASD is significant. However, clinically standardized screening tests are considered a prolonged diagnostic time, which is prone to errors and also leads to a rise in medical costs. Therefore, to decrease the time required for diagnosis and improve the precision of the model, AI (artificial intelligence) (machine learning (ML)) techniques are used to complement other traditional methods. Hence, this study has proposed a modified deep dynamic Levenberg–Marquardt (DDLM) optimized approach, which enhances the accuracy and classifier’s precision for implementing binary classification of children with ASD and children without ASD and tackles the issues in early detection. The process starts by preprocessing the data using label encoding and feature scaling techniques for eradicating irrelevant and noisy data, and then classification proceeds by utilizing the modified DDLM model. The dataset used in the proposed model is an amalgamation of datasets, which are ASD meta‐abundance and GSE113690_Autism_16S_rRNA. Additionally, a comparison of classifiers with three ML‐based algorithms, namely, MLP (multilayer perceptron), NB (naïve Bayes), and XGBoost (extreme gradient boost), is performed to analyze the effectiveness of the proposed system in the binary classification of ASD. The efficacy of the proposed system is evaluated using performance factors such as specificity, precision, F 1‐score, accuracy, and recall.